Monday, February 9, 2026
Home Tags ADHD treatment

Tag: ADHD treatment

Granules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)
Brands in Conversation

Granules Pharmaceuticals, Inc. Receives FDA Tentative Approval with 180-Day Exclusivity for Generic Amphetamine Extended-Release Tablets (gDYANAVEL XR)

Author -
0
Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)
Brands in Conversation

Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)

Author -
0
Glenmark Pharmaceuticals to Launch Mixed Salts of a Single Entity Amphetamine Tablets in Various Strengths
Brands in Conversation

Glenmark Pharmaceuticals to Launch Mixed Salts of a Single Entity Amphetamine Tablets in Various Strengths

Author -
0
Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules
Brands in Conversation

Granules Strengthens ADHD Portfolio with FDA Approval for Lisdexamfetamine Dimesylate Capsules

Passionate in Marketing -
0
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Brands in Conversation

Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.

Passionate in Marketing -
0

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

© 2026 | Passionate In Marketing |All Rights Reserved | Privacy Policy